0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538

Graceptor- Drug Insight, 2019

Published Date: March 2019
|
Report Code: DELV-DRIN-033
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Gracepto Drug Insight 2019

Graceptor- Drug Insight, 2019

Code: DELV-DRIN-033
Report
March 2019
35 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's pharmaceuticals report, "Graceptor Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Graceptor covering the historical global sales and also provides the Graceptor sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Graceptor and emerging therapies in this space.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
• A review of the Graceptor, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Graceptor
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Graceptor`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Graceptor with DelveInsight`s SWOT analysis

1. DelveInsight Report Introduction
2. Graceptor- Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Regulatory Milestones by Region
• Deals and Partnerships
3. Product Details
4. Graceptor Sales Assessment
• Historical Sales
• Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
• Product Description
• Research and Development
• Product Development Activities
9. SWOT Analysis
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us
Disclaimer

List for Tables :

Table 1: Graceptor, Description
Table 2: Product Details
Table 3: Graceptor, Historical Sales till 2018 (in million USD)
Table 4: Graceptor, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Graceptor Major Competitors
Table 9: Emerging Therapies

List for Figure :

Figure 1: Graceptor, Historical Global Sales till 2018 (in million USD)
Figure 2: Graceptor, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region

Introduction
DelveInsight's pharmaceuticals report, "Graceptor Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Graceptor covering the historical global sales and also provides the Graceptor sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Graceptor and emerging therapies in this space.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
• A review of the Graceptor, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Graceptor
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Graceptor`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Graceptor with DelveInsight`s SWOT analysis

Read More

1. DelveInsight Report Introduction
2. Graceptor- Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Regulatory Milestones by Region
• Deals and Partnerships
3. Product Details
4. Graceptor Sales Assessment
• Historical Sales
• Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
• Product Description
• Research and Development
• Product Development Activities
9. SWOT Analysis
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us
Disclaimer

Read More

List for Tables :

Table 1: Graceptor, Description
Table 2: Product Details
Table 3: Graceptor, Historical Sales till 2018 (in million USD)
Table 4: Graceptor, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Graceptor Major Competitors
Table 9: Emerging Therapies

List for Figure :

Figure 1: Graceptor, Historical Global Sales till 2018 (in million USD)
Figure 2: Graceptor, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region

Read More

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$1000
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$2000
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$3000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

Acute Lymphocytic Lymphoblastic Leukemia ALL Therapeutics Market by Drug Hyper CVAD Regimen Linker Regimen Nucleoside Metabolic Inhibitors Targeted Drugs Immunotherapy CALGB 8811 Regimen and Oncaspar and Type Pediatric and Adult Global Opportunity Analysis and Industry Forecast 2019 2026
Acute Lymphocytic Lymphoblastic Leukemia ALL Therapeutics Market by Drug Hyper CVAD Regimen Linker Regimen Nucleoside Metabolic Inhibitors Targeted Drugs Immunotherapy CALGB 8811 Regimen and Oncaspar and Type Pediatric and Adult Global Opportunity Analysis and Industry Forecast 2019 2026

Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market by Drug (Hyper-CVAD Regimen, Linker Regimen, Nucleoside Metabolic Inhibitors, Targeted Drugs & Immunotherapy, CALGB 8811 Regimen, and Oncaspar), and Type (Pediatric and Adult): Global Opportunity Analysis and Industry Forecast, 2019–2026

120 Pages
Type: Report
Code: ALLI-Auto-4M353
Wed Nov 20 00:00:00 UTC 2019

Add to Cart

Bioinformatics Market by Technology and Services Knowledge Management Tools Bioinformatics Platforms and Bioinformatics Services Application Metabolomics Molecular Phylogenetics Transcriptomics Proteomics Chemoinformatics Genomics and Others and Sector Medical Bioinformatics Animal Bioinformatics Agriculture Bioinformatics Academics and Others Global Opportunity Analysis and Industry Forecast 2018 2025
Bioinformatics Market by Technology and Services Knowledge Management Tools Bioinformatics Platforms and Bioinformatics Services Application Metabolomics Molecular Phylogenetics Transcriptomics Proteomics Chemoinformatics Genomics and Others and Sector Medical Bioinformatics Animal Bioinformatics Agriculture Bioinformatics Academics and Others Global Opportunity Analysis and Industry Forecast 2018 2025

Bioinformatics Market by Technology and Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, and Others), and Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

120 Pages
Type: Report
Code: ALLI-Auto-0B326
Wed Nov 20 00:00:00 UTC 2019

Add to Cart

Biomarker Technologies Market by Product Consumables and Instruments Technology Polymerase Chain Reaction PCR Next Generation Sequencing NGS Immunoassay and Others and Application Drug Discovery Diagnostics and Personalized Medicine and Indication Cancer Infectious Diseases Autoimmune Disorders Cardiovascular Disorders and Others Global Opportunity Analysis and Industry Forecast 2019 2026
Biomarker Technologies Market by Product Consumables and Instruments Technology Polymerase Chain Reaction PCR Next Generation Sequencing NGS Immunoassay and Others and Application Drug Discovery Diagnostics and Personalized Medicine and Indication Cancer Infectious Diseases Autoimmune Disorders Cardiovascular Disorders and Others Global Opportunity Analysis and Industry Forecast 2019 2026

Biomarker Technologies Market by Product (Consumables, and Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), and Application (Drug Discovery, Diagnostics, and Personalized Medicine), and Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

120 Pages
Type: Report
Code: ALLI-Auto-4F346
Wed Nov 20 00:00:00 UTC 2019

Add to Cart

Biotechnology Media Sera and Reagents Market by Type Media Sera and Reagent Application Cancer Research Biopharmaceuticals Regenerative Medicine Tissue Engineering and Others and End User Biotechnology Pharmaceutical Companies Academic Institute Research Laboratory Global Opportunity Analysis and Industry Forecast 2018 2025
Biotechnology Media Sera and Reagents Market by Type Media Sera and Reagent Application Cancer Research Biopharmaceuticals Regenerative Medicine Tissue Engineering and Others and End User Biotechnology Pharmaceutical Companies Academic Institute Research Laboratory Global Opportunity Analysis and Industry Forecast 2018 2025

Biotechnology Media, Sera and Reagents Market by Type (Media, Sera and Reagent), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, and Others), and End User (Biotechnology & Pharmaceutical Companies, Academic Institute, Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

120 Pages
Type: Report
Code: ALLI-Auto-2W329
Wed Nov 20 00:00:00 UTC 2019

Add to Cart

0 Items
X
No items in the cart.
$0.0